Management
"HemoBioTech, Inc. is supported by strong management and a distinguished scientific and advisory team"
-- Arthur P. Bollon, Ph.D.
(President, Chairman & Chief Executive Officer)
Arthur P. Bollon, Ph.D.
Chairman of the Board of Directors, President and Chief Executive Officer
Mark J. Rosenblum, C.P.A.
Chief Financial Officer
Mario Feola, M.D.
Chief Medical Officer
Jan Simoni, Ph.D., D.V.M.
Acting Vice President, Research and Development and Advisor
- Arthur P. Bollon, Ph.D.
- Dr. Bollon brings 25 years experience in biotechnology as a scientist, executive and entrepreneur. He has been the Chairman, President and CEO of HemoBioTech since 2003.
- Founder, former Chairman & CEO of Wadley Biosciences Inc., a joint venture between Wadley Cancer Center and Phillips Petroleum.
- Founder, former Chairman & CEO of Cytoclonal Pharmaceutics – led an IPO in 1995 and closed licensing agreement with Bristol Meyers Squibb.
- Dr. Bollon holds a Ph.D. in molecular genetics from Rutgers University and was a Post Doctoral Fellow at Yale University.
- Mark J. Rosenblum, C.P.A.
- Mark Rosenblum joined as the Chief Financial Officer of HemoBioTech on April 1, 2005.
- Former Vice President, Chief Accounting Officer & Controller at Wellman, Inc., a $1.2 billion public chemical manufacturer.
- Mark Rosenblum holds a master's in accounting and B.S. in accounting from the University of South Carolina. Mr. Rosenblum is also a certified public accountant.
- Jan Simoni, Ph.D., D.V.M.
- Dr. Simoni is the co-inventor of HemoTech™ and a world-renowned blood substitute scientist.
- He is the Acting Vice President of R & D and Advisor at HemoBioTech and Associate Research Professor of Surgery and Internal Medicine at Texas Tech University Health Science Center.
- Co-author of over 100 publications, book chapters, and abstracts on human blood substitutes.
- Dr. Simoni holds a DVM and a Ph.D. from Wroclaw Agricultural University in Poland.
- Mario Feola, M.D.
- Dr. Feola is the co-inventor of HemoTech™ & a renowned blood substitute scientist
- He is the Chief Medical Officer of HemoBioTech. Co-authored over 100 scientific publications.
- Former Professor of Surgery at Texas Tech University Health Science Center & Chief of Surgery, VA Hospital.
- Dr. Feola holds an M.D. degree from University of Naples, Italy.